Friday, 22 May 2015
Topics
Meeting category
Date(s)
22 May 2015 - 23 May 2015
Location
Xi'an,
China
Organizer
Platinum Level Support
Sponsor logos
Asian Conference on Hepatitis and AIDS (ACHA) 2015
Related Enduring Materials
Enduring Materials
-
Opening Words
Polin Chan, MD
World Health Organization, China
Session 1: HIV -
The Advance and Challenge about cART in China
Treatment Failure and PI Monotherapy
Longterm Complications of HIV Treatment
Opportunities and Challenges of HIV Vaccine Research
HIV Functional Cure
Xiaoping Tang, MD, PhD
Guangzhou 8th People's Hospital, China
AbbVie-supported Symposium: 2nd line HIV ART in Resource Limited Settings -
Chair
Second-line ART in Resource Limited Settings
Free ARV Therapy in Yunnan Province
Huiqin Li
Yunan AIDS Caring Center, China
Session 2: HBV -
Stephen Locarnini, BSc(Hons), PhD, MBBS, FRC(Path)
Current Treatment Options for Hepatitis B
New HBV Treatment Options on the Horizon
HBV Infection in Special Populations and Its Control Strategy
How to Achieve Cure in HBV: A Virological Perspective
Victorian Infectious Diseases Reference Laboratory
New Biomarkers for Chronic Hepatitis B
Saturday, 23 May 2015
Session 3: HCV -
Hepatitis C Virus Infection Epidemiology and Management： Challenges We Are Facing in China
Xiaochun Wang, MSc, DrPH
Chinese CDC, China
Viral and Cellular Factors Important for Hepatitis C Virus Infection and Replication in Vitro and in Vivo
Current Treatment Challenges of Hepatitis C
Session 4: Hepatitis Co-infection -
Transmission Bottleneck of HIV-1 and HCV in Chinese Injected Drug Users
Fan Li, MD
China CDC, China
Treatment in Special Clinical Populations
AbbVie-supported Symposium: Current Advances in the Treatment of Chronic Hepatitis C - Does Hard to Treat Exist Anymore?
David Iser, PhD, FRACP
IsNorth West Specialist Centre, Australia
Session 5: Future Challenges -
Stephen Locarnini, BSc(Hons), PhD, MBBS, FRC(Path)
National Free Antiretroviral Therapy and Outcomes in China
Challenges in HCV: Policy and Advocacy
Victorian Infectious Diseases Reference Laboratory
Challenges in Viral Hepatitis: Community Perspectives
Global and Regional Hepatitis Action Plan – Future Opportunity and Consideration in China
Overview
Support
Endorsers
Language
Related Programs
